Download PDF
Semin Musculoskelet Radiol 2001; 05(1): 021-034
DOI: 10.1055/s-2001-12922
Copyright © 2001 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Contrast-enhanced Magnetic Resonance Imaging of Bone Marrow

Henk-Jan Van der Woude1 , Michael Egmont-Petersen2
  • 1Department of Radiology, Onze Lieve Vrouwe Gasthuis, Amsterdam
  • 2Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands
Further Information

Publication History

Publication Date:
31 December 2001 (online)

Also available at
    Permissions and Reprints

ABSTRACT

In the assessment with magnetic resonance (MR) imaging of bone marrow disorders, the use of contrast agents is usually not critical because T1-weighted spin-echo and fat-suppressed sequences (STIR or fat-sat intermediate weighted) are robust and largely available techniques for depiction of neoplastic and non-neoplastic lesions of the bone marrow. This article discusses the characteristics of dynamic contrast-enhanced MR imaging of bone marrow edema, ischemia, and neoplasm. It emphasizes its value in staging and in monitoring of response to chemotherapy of several bone tumors. These fast dynamic contrast-enhanced techniques do not allow differentiation between benign and malignant primary osseous tumors because the biologic behavior rather than the malignant potential of these lesions is reflected.

KEYWORD

Magnetic resonance imaging - contrast agent - magnetic resonance imaging - rapid imaging - bone marrow - edema - bone marrow - ischemia - bone - neoplasms - chemotherapy

REFERENCES

  • 1 Porter B A, Deutsch A L. Marrow. In: Deutch AL, Mink JH, eds. MRI of the Musculoskeletal System-A Teaching File, 2nd ed Philadelphia, PA: Lippincott-Raven 1997: 585-613
    Google Scholar
  • 2 Algra P R, Bloem J L. Magnetic resonance imaging of metastatic disease and multiple myeloma. In: Bloem JL, Sartoris DJ, eds. MRI and CT of the Musculoskeletal System Baltimore: Williams & Wilkins 1992: 218-235
    Google Scholar
  • 3 Baur A, Stabler A, Bartl R, Lamerz R, Scheidler J, Reiser M. MRI gadolinium enhancement of bone marrow: age-related changes in normals and in diffuse neoplastic infiltration.  Skeletal Radiol . 1997;  26 414-418
    CrossrefPubMedGoogle Scholar
  • 4 Bollow M, Knauf W, Korfel A. Initial experience with dynamic MR imaging in evaluation of normal bone marrow versus malignant bone marrow infiltrations in humans.  J Magn Reson Imaging . 1997;  7 241-250
    CrossrefPubMedGoogle Scholar
  • 5 Cova M, Kang Y S, Tsukamoto H. Bone marrow perfusion evaluated with gadolinium-enhanced dynamic fast MR imaging in a dog model.  Radiology . 1991;  179 535-539
    CrossrefPubMedGoogle Scholar
  • 6 Sakai T, Sugano N, Tsuji T. Contrast-enhanced magnetic resonance imaging in a nontraumatic rabbit osteonecrosis model.  J Orthop Res . 1999;  17 784-792
    CrossrefPubMedGoogle Scholar
  • 7 Vande Berg C B, Malghem J J, Labaisse M A, Noel H M, Maldague B E. MR imaging of avascular necrosis and transient marrow edema of the femoral head.  Radiographics . 1993;  13 501-520
    PubMedGoogle Scholar
  • 8 Vande Berg C B, Malghem J J, Lecouvet F E, Jamart J, Maldague B E. Idiopathic bone marrow edema lesions of the femoral head: predictive value of MR imaging findings.  Radiology . 1999;  212 527-535
    PubMedGoogle Scholar
  • 9 Imhof H, Breitenseher M, Trattnig S. Imaging of avascular necrosis of bone.  Eur Radiol . 1997;  7 180-186
    CrossrefPubMedGoogle Scholar
  • 10 Morrison W B, Schweitzer M E, Bock G W. Diagnosis of osteomyelitis: utility of fat-suppressed contrast-enhanced MR imaging.  Radiology . 1993;  189 251-257
    CrossrefPubMedGoogle Scholar
  • 11 Blum U, Buitrago-Tellez C, Mundinger A. Magnetic resonance imaging (MRI) for detection of active sacroiliitis-a prospective study comparing conventional radiography, scintigraphy, and contrast-enhanced MRI.  J Rheumatol . 1996;  23 2107-2115
    PubMedGoogle Scholar
  • 12 Kroon H M, Bloem J L, Holscher H C, Van der Woude J H, Reijnierse M, Taminiau A HM. MR imaging of edema accompanying benign and malignant bone tumors.  Skeletal Radiol . 1994;  23 261-269
    PubMedGoogle Scholar
  • 13 Van der Woude J H, Bloem J L, Verstraete K L, Taminiau A HM, Nooy M A, Hogendoorn P CW. Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery.  AJR . 1995;  165 593-598
    PubMedGoogle Scholar
  • 14 Verstraete K L, De Deene Y, Roels H, Dierick A, Uyttendaele D, Kunnen M. Benign and malignant musculoskeletal lesions: dynamic contrast-enhanced MR imaging-parametric ``first-pass'' images depict tissue vascularization and perfusion.  Radiology . 1994;  192 835-843
    CrossrefPubMedGoogle Scholar
  • 15 Van der Woude J H, Verstraete K L, Hogendoorn P CW, Taminiau A HM, Hermans J, Bloem J L. Musculoskeletal tumors: does fast contrast-enhanced subtraction MR imaging contribute to the characterization?.  Radiology . 1998;  208 821-828
    PubMedGoogle Scholar
  • 16 Rahmouni A, Divine M, Mathieu D. ME appearance of multiple myeloma of the spine before and after treatment.  AJR . 1993;  160 1053-1057
    PubMedGoogle Scholar
  • 17 Lecouvet F E, De Anyer P, Garbar C. Treated plasma cell lesions of bone with MRI signs of response to treatment: unexpected pathological findings.  Skeletal Radiol . 1998;  27 692-695
    CrossrefPubMedGoogle Scholar
  • 18 Bloem J L, Taminiau A HM, Eulderink F, Hermans J, Pauwels E KJ. Radiologic staging of primary bone sarcoma: MR imaging, scintigraphy, angiography and CT correlated with pathologic examination.  Radiology . 1988;  169 805-810
    PubMedGoogle Scholar
  • 19 Geirnaerdt M JA, Bloem J L, Eulderink F, Hogendoorn P CW, Taminiau A HM. Cartilaginous tumors: correlation of gadolinium-enhanced MR imaging and histopathologic findings.  Radiology . 1993;  186 813-817
    PubMedGoogle Scholar
  • 20 Geirnaerdt M JA, Hogendoorn P CW, Bloem J L, Taminiau A HM, Van der Woude J H. Cartilaginous tumors: fast contrast-enhanced MR imaging.  Radiology . 2000;  214 539-546
    CrossrefPubMedGoogle Scholar
  • 21 Geirnaerdt M JA, Bloem J L, Van der Woude J H, Taminiau A HM, Nooy M A, Hogendoorn P CW. <~>Chondroblastic osteosarcoma: characterization by gadolinium-enhanced MR imaging correlated with histopathology.  Skeletal Radiol . 1998;  27 145-153
    CrossrefPubMedGoogle Scholar
  • 22 Hawighorst H, Libicher M, Knopp M V, Moehler T, Kauffmann G W, Van Kaick G. Evaluation of angiogenesis and perfusion of bone marrow lesions: role of semiquantitative and qualitative dynamic MRI.  J Magn Reson Imaging . 1999;  10 903-907
    CrossrefPubMedGoogle Scholar
  • 23 Egmont-Petersen M, Hogendoorn P CW, Van der Geest. Detection of areas with viable remnant tumor in postchemotherapy patients with Ewing's sarcoma by dynamic contrast-enhanced MRI using pharmacokinetic modeling.  Magn Res Imaging . 2000;  18 525-535
    PubMedGoogle Scholar
  • 24 Rahmouni A, Divine M, Mathieu D. Detection of multiple myeloma involving the spine: efficacy of fat-suppression and contrast-enhanced MR imaging.  AJR . 1993;  160 1049-1052
    PubMedGoogle Scholar
      >